A porous bone repair scaffold with photothermal function, its preparation method and application
By preparing a porous bone repair scaffold containing phosphomolybdenum clusters and using exogenous laser modulation to achieve precise control of photothermal properties, the limitations of existing bone repair materials in the treatment of deep tissue diseases have been solved, providing a wider range of applications and greater biocompatibility.
Patent Information
- Application Number
- CN202510637912.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-05-16
- Publication Date
- 2026-11-17
AI Technical Summary
Existing bone repair materials have limitations in the treatment of diseases such as bone tumors and bone infections. Their photothermal properties are concentrated in the near-infrared region, which makes it difficult to meet the treatment needs of deep tissue diseases. Furthermore, their preparation methods are cumbersome and their application conditions are demanding.
A porous bone repair scaffold containing phosphomolybdenum clusters is used, and the photothermal performance is precisely controlled by external laser modulation. The scaffold is composed of supporting materials, active components and thermal effect components. The phosphomolybdenum clusters endow the scaffold with photothermal function and are prepared by melt 3D printing.
It has achieved important roles in antibacterial, tumor treatment and bone regeneration promotion. Near-infrared II laser has better biosafety, deeper tissue penetration, and wider application fields. It slowly releases phosphorus and molybdenum during degradation, providing biosafety.
Smart Images

Figure CN123101736A_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the field of biomaterials, and more specifically, to a porous bone repair scaffold with photothermal function, its preparation method, and its application. Background Technology
[0002] Bones are an important tissue in the human body, mainly composed of inorganic minerals, type I collagen, and various cells. In recent years, the number of patients with bone injuries caused by trauma, infection, tumors, and aging has been enormous, creating a significant clinical shortage of orthopedic repair materials.
[0003] Currently, the most researched synthetic bone repair materials include metallic materials, inorganic bone cement, bioglass, and organic polymers. However, each material has its unique advantages and limitations; single materials often lack sufficient osteogenic activity to meet the complex needs of bone regeneration. Furthermore, bone defect treatment is frequently accompanied by bone tumors, bone infections, and other complications, which place multifaceted performance demands on bone repair materials. Among these, utilizing stimulus-responsive active factors, particularly laser-induced thermal effects, to regulate cell behavior—including promoting cell differentiation and inhibiting bacterial or tumor cell activity—holds immense potential in the biomedical field, especially in antibacterial, antitumor, and bone repair applications.
[0004] Chinese patent CN118662708A discloses a biodegradable hierarchical porous composite scaffold with near-infrared light response and its preparation method. This biodegradable hierarchical porous composite scaffold possesses photothermal anti-tumor, bone repair, spontaneous degradation, and essential mechanical support functions for bones. Furthermore, the scaffold prepared by 3D printing has multiple small pores, thus providing space and nutrients for cell growth while also exhibiting photothermal effects, which is beneficial for cell adhesion and migration. However, the photothermal properties of the material prepared in this patent are mainly concentrated in the near-infrared region I (808nm), which limits its application in the treatment of deep tissue diseases.
[0005] Chinese patent CN118787781A discloses a near-infrared light-responsive scaffold for treating avascular necrosis of the femoral head, its preparation method, and its application. The scaffold is fabricated by 3D printing after uniformly mixing picaridin-loaded black phosphorus nanosheets with PLGA and β-TCP materials. The doping of the picaridin-loaded black phosphorus nanosheets with BPICT imparts good near-infrared light-responsive properties to the scaffold, which is beneficial for bone repair and promotes the treatment of avascular necrosis of the femoral head. However, PLGA is hydrophobic, which is detrimental to cell adhesion and proliferation in the application of bone repair scaffolds. Furthermore, the scaffold preparation method is cumbersome and the application conditions are demanding, which also limits its application.
[0006] Therefore, developing a light-responsive bone repair scaffold with good therapeutic effects and simple application is an urgent problem to be solved. Summary of the Invention
[0007] To address the aforementioned issues, this invention provides a porous bone repair scaffold with photothermal function and its preparation method. The scaffold contains thermal effect components, and its photothermal properties can be precisely controlled by external laser modulation, thereby playing an important role in fields such as antibacterial activity, tumor treatment, or bone regeneration promotion.
[0008] Firstly, one of the objectives of this invention is to provide a porous bone repair scaffold with photothermal function.
[0009] Specifically, the scaffold comprises components including a supporting material, an active component, and a thermally effective component, wherein the thermally effective component is a reduced state of phosphomolybdenum cluster.
[0010] Furthermore, the phosphomolybdate cluster is selected from one or a combination of phosphomolybdic acid or phosphomolybdate salts. The chemical formula of phosphomolybdic acid is H3PMo. 12 O 40 • H₂O; The phosphomolybdenum salt is selected from one or a combination of ammonium or sodium salts, and the chemical formula of the ammonium phosphomolybdenum salt is (NH₄)₆P₂Mo. 18 O 62 ·12H2O, the chemical formula of sodium phosphomolybdate is Na5PMo 10 V2O 40 .
[0011] It is worth mentioning that the present invention uses inorganic clusters (such as phosphomolybdic acid and phosphomolybdate salt) containing phosphorus and molybdenum with strong oxidizing properties to apply to the stent. On the one hand, this gives the stent photothermal function. On the other hand, phosphorus is an essential element for the human body, and molybdenum is an essential trace element for the human body. Moreover, the content of phosphomolybdate clusters in the stent is low, and they can be slowly released as the stent degrades to provide what the human body needs, thus having high biosafety.
[0012] It should be noted that phosphomolybdic acid and phosphomolybdate salts are types of polyacids, belonging to different branches of the polyacid family. The aforementioned phosphomolybdate clusters exhibit good photothermal effects when applied to scaffolds. Furthermore, the phosphomolybdic acid (CAS: 51429-74-4) used in this case is commercially available; the ammonium phosphomolybdate salt is prepared using methods disclosed in the prior art (reference J. Mater. Chem., 2002, 12, 299–304, DOI: 10.1039 / b106769a); and the sodium phosphomolybdate salt is also prepared using methods disclosed in the prior art (reference Inorg. Chem. 1967, 7, 437–441, DOI: 10.1021 / ic50061a009).
[0013] Furthermore, in the aforementioned scaffold, the mass ratio of the supporting material to the active component is 2.5–20:1, preferably 5–10:1. This ratio of active component in the scaffold not only endows the scaffold material with bioactivity but also allows it to maintain good mechanical properties. In addition, since the degradation products of the supporting material are acidic and can trigger inflammatory responses, the introduction of the aforementioned ratio of active component can effectively promote bone regeneration, neutralize acidity, and reduce inflammatory responses.
[0014] Furthermore, in the aforementioned scaffold, the supporting material is selected from biodegradable copolymers; preferably, lactic acid copolymers are used. It is worth mentioning that polylactic acid (PLA) is widely used in bone repair due to its excellent biodegradability and biocompatibility; however, its poor water solubility limits its application to some extent. This invention, through modification of PLA, obtains a lactic acid copolymer with significantly improved hydrophilicity. This not only makes the scaffold material more convenient to prepare and use but also greatly reduces immune rejection reactions when the scaffold is used in vivo.
[0015] Preferably, the lactic acid copolymer is formed by copolymerizing lactide and polyethylene glycol, with a molecular weight Mn of 5–10 w, preferably 7–10 w; the molecular weight of polyethylene glycol (PEG) in the lactic acid copolymer is 8000–20000. Since the lactic acid copolymer contains hydrophilic polyethylene glycol (PEG) segments, the introduction of PEG segments can effectively improve the hydrophilicity of the polymer and endow the scaffold with good hydrophilicity. It should be noted that the lactic acid copolymer can be prepared by methods disclosed in the prior art (Reference: Adv. Funct. Mater. 2017, 1604784, DOI: 10.1002 / adfm.201604784). Figure 13a The contact angle diagram of the purchased polylactic acid is shown. Figure 13b The contact angle diagram of the lactic acid copolymer used in this invention is shown. Figure 13a As can be seen from b, the hydrophilicity of the lactic acid copolymer used in this invention is significantly better than that of polylactic acid.
[0016] Preferably, the active component is selected from one or a combination of hydroxyapatite and tricalcium phosphate. Hydroxyapatite is the main inorganic component of bone and can accelerate bone ingrowth into the surface of biomedical implants; tricalcium phosphate is a bioabsorbable calcium phosphate ceramic whose controllable degradation characteristics can match the rate of new bone formation, thereby providing an ideal microenvironment for bone regeneration.
[0017] Furthermore, in the above-mentioned support, the mass of the thermal effect component is 0.1 to 3 wt% of the mass of the support material, preferably 0.25 to 2 wt%, and more preferably 0.5 to 1 wt%.
[0018] Secondly, another objective of the present invention is to provide a method for preparing a porous bone repair scaffold with photothermal function, which is one of the objectives of the present invention.
[0019] Specifically, the preparation method includes the following steps:
[0020] Step 1: Dissolve the support material in solvent A and the phosphomolybdenum cluster in solvent B respectively, then mix them evenly, add the active component and stir for a certain period of time to form a mixed solution;
[0021] Step 2: Dry the mixed solution and process it into a porous bone repair scaffold under high temperature conditions.
[0022] Furthermore, in step one,
[0023] Solvent A is one or a combination of dichloromethane and trichloromethane;
[0024] Solvent B is one or a combination of methanol and ethanol;
[0025] The mixing time after mixing is 6 to 24 hours.
[0026] It is worth mentioning that the aforementioned solvent can promote better integration of the support material, phosphomolybdenum cluster, and active components, which is beneficial for the fabrication of the scaffold.
[0027] Preferably, in step one, the mass ratio of the support material to the active component is 2.5 to 20:1, more preferably 5 to 10:1; the mass of the phosphomolybdenum cluster is 0.1 to 3 wt% of the mass of the support material, more preferably 0.25 to 2 wt%, and particularly preferably 0.5 to 1 wt%.
[0028] Furthermore, in step two, the processing method employs fused 3D printing. Preferably, the temperature during 3D printing is 160℃~180℃, more preferably 165~170℃. It is worth mentioning that, during the thermal processing, this invention reduces the phosphomolybdenum cluster to a reduced state, ensuring that the Mo element in the phosphomolybdenum cluster only undergoes a change in valence state and does not damage the skeletal structure of the phosphomolybdenum cluster, thus giving the scaffold excellent photothermal performance.
[0029] Preferably, the pore size of the 3D-printed scaffold is 200–1000 μm, and more preferably 300–800 μm.
[0030] Furthermore, a third objective of this invention is to provide the application of a porous bone repair scaffold with photothermal function, which is one of the objectives of this invention.
[0031] Specifically, the scaffold is used to repair bone tissue, and a laser is used to regulate the temperature of the scaffold during bone tissue repair.
[0032] Preferably, the temperature range of the above-mentioned support is 0–70°C, more preferably 10–60°C, even more preferably 20–50°C, particularly preferably 25–45°C, and most preferably 36–42°C. In application, the optimal applicable temperature can be selected according to specific circumstances.
[0033] Preferably, the wavelength of the laser that the above-mentioned support responds to is in the near-infrared band of 750-1500nm, more preferably in the near-infrared II band of 1000-1500nm, and especially in the near-infrared II band of 1000-1350nm, when the support has better photothermal conversion performance.
[0034] It is worth mentioning that the near-infrared II band has a deeper tissue penetration depth and higher biosafety. The scaffold provided by this invention has better application performance in the near-infrared II band and has higher application value in the biomedical field.
[0035] Preferably, the laser irradiation time is 0 to 30 minutes, more preferably 5 to 10 minutes, to reach the predetermined temperature.
[0036] Compared with the prior art, the beneficial effects of the present invention are as follows:
[0037] 1. This invention provides a fabrication technique for a porous bone repair scaffold with photothermal function. A biodegradable lactic acid copolymer is uniformly mixed with phosphomolybdate clusters and active components, and then melt-printed to obtain a bone repair scaffold with photothermal properties. The lactic acid copolymer provides structural support, the active components enhance osteoinductive properties, and the phosphomolybdate clusters are reduced to a reduced state in the high-temperature environment of melt-printing, thereby endowing the bone repair scaffold with photothermal properties. Under external laser control, the photothermal properties of the porous scaffold can be precisely controlled, thereby controlling the generation and intensity of the thermal effect, and thus playing an important role in antibacterial activity, tumor treatment, and promoting bone regeneration.
[0038] 2. This invention provides a porous bone repair scaffold with photothermal function, which has better biosafety and deeper tissue penetration in the near-infrared II laser zone, and has a wider range of applications.
[0039] 3. This invention provides a biodegradable porous bone repair scaffold with photothermal function. By introducing photothermal materials into the composite system, the scaffold function is further enriched. While improving the osteogenic activity of the scaffold, it can be used to treat bone-related diseases, which has important application value. Attached Figure Description
[0040] Figure 1 The image shows the mixed solution of lactic acid copolymer, hydroxyapatite, and phosphomolybdenum clusters prepared in step one of Example 3 of the present invention.
[0041] Figure 2a~f are images of the stents prepared in Examples 1-4 and Comparative Examples 1-2 of the present invention;
[0042] Figure 3 Infrared spectra of the scaffold prepared in Example 3 of the present invention, the lactic acid copolymer prepared in step one of Example 3, the mixed solution of hydroxyapatite and phosphomolybdenum ammonium, phosphomolybdenum ammonium, hydroxyapatite, and lactic acid copolymer;
[0043] Figure 4 Infrared spectra of the stents prepared in Examples 1-4 of this invention;
[0044] Figure 5 The high-resolution XPS peak fitting spectrum of the Mo 3d orbital in the mixed solution of lactic acid copolymer, hydroxyapatite and phosphomolybdenum ammonium prepared in step one of Example 4 of the present invention is shown.
[0045] Figure 6 This is the high-resolution XPS peak fitting spectrum of the Mo 3d orbitals in the scaffold prepared in Example 4 of the present invention;
[0046] Figure 7 The absorption spectra of the stents prepared in Examples 1-4 and Comparative Example 3 of this invention are shown below.
[0047] Figure 8 The above are the temperature rise curves of the stents prepared in Examples 1-4, Comparative Examples 1 and 3 of the present invention.
[0048] Figure 9 The images show thermal images of the stents prepared in Examples 1-4, Comparative Examples 1 and 3 of the present invention.
[0049] Figure 10 The temperature rise curves of the support prepared in Example 3 of this invention under different light irradiation powers are shown.
[0050] Figure 11 The thermal images of the support prepared in Embodiment 3 of the present invention under different light irradiation powers are shown below.
[0051] Figure 12 The temperature change curve of the stent prepared in Example 3 of the present invention during five consecutive reversible cycles of laser irradiation / shutdown;
[0052] Figure 13a ~b shows the contact angle test images of purchased polylactic acid (PLA, Mn=8w) and the lactic acid copolymer used in this invention (Mn=7.5w, of which the molecular weight of polyethylene glycol (PEG) block Mn=2w) with water;
[0053] Figure 14 The above are the temperature rise curves of the stents prepared in Examples 3, 5, 6 and Comparative Example 4 of this invention. Detailed Implementation
[0054] The present invention will now be described in detail with reference to the accompanying drawings and embodiments. It should be noted that the following embodiments are only used to further illustrate the present invention and should not be construed as limiting the scope of protection of the present invention. Some non-essential improvements and adjustments made by those skilled in the art based on the content of the present invention are still within the scope of protection of the present invention.
[0055] In the following examples and comparative examples, the raw materials were sourced from commercially available products or prepared by known methods. Among them, polylactic acid (PLA, Mn=8w) was purchased from Shanghai Maclean Biochemical Technology Co., Ltd.
[0056] Example 1
[0057] This embodiment illustrates the preparation of a porous bone repair scaffold with photothermal function. The specific steps are as follows:
[0058] Step 1: Dissolve 2g of lactic acid copolymer (Mn = 7.5w, where the molecular weight of the polyethylene glycol (PEG) block is Mn = 2w) in 4mL of chloroform, and add 0.005g of ammonium phosphomolybdate ((NH4)6P2Mo 18 O 62 Dissolve 12H2O in 0.1 mL of methanol, mix the two thoroughly, add 0.2 g of hydroxyapatite, and stir overnight at room temperature.
[0059] Step 2: Pour the mixed solution into a polytetrafluoroethylene mold and let it dry, then place it in a vacuum oven to dry the solvent.
[0060] Step 3: At 160°C, the above mixture is 3D printed into a 20mm×20mm×1mm porous scaffold (referred to as 0.25% PHMo) with a pore size of 500μm.
[0061] The photothermal conversion performance of the composite material was verified by irradiating it with a 1064nm laser.
[0062] Lighting conditions: Illumination power is 0.1W cm -2 The light exposure distance was 1 cm, and the light exposure time was 10 min.
[0063] Under laser irradiation, the temperature of the porous stent rose rapidly, from an initial 25.5℃ to 41.1℃. The temperature increased quickly in the first 3 minutes, then plateaued and stabilized.
[0064] Example 2
[0065] This embodiment illustrates the preparation of a porous bone repair scaffold with photothermal function. The specific steps are as follows:
[0066] Step 1: Dissolve 2g of lactic acid copolymer (Mn = 7.5w, where the molecular weight of the polyethylene glycol (PEG) block is Mn = 2w) in 4mL of chloroform, and add 0.01g of ammonium phosphomolybdate (NH4)6P2Mo 18 O 62 Dissolve 12H2O in 0.1 mL of methanol, mix the two thoroughly, add 0.2 g of hydroxyapatite, and stir overnight at room temperature.
[0067] Step 2: Pour the mixed solution into a polytetrafluoroethylene mold and let it dry, then place it in a vacuum oven to dry the solvent.
[0068] Step 3: At 160°C, the above mixture is 3D printed into a 20mm×20mm×1mm porous scaffold (referred to as 0.5% PHMo) with a pore size of 500μm.
[0069] The photothermal conversion performance of the composite material was verified by irradiating it with a 1064nm laser.
[0070] Lighting conditions: Illumination power is 0.1W cm -2 The light exposure distance was 1 cm, and the light exposure time was 10 min.
[0071] Under laser irradiation, the temperature of the porous stent rose rapidly, from an initial 25.5℃ to 43.6℃. The temperature increased quickly in the first 3 minutes, then plateaued and stabilized.
[0072] Example 3
[0073] This embodiment illustrates the preparation of a porous bone repair scaffold with photothermal function. The specific steps are as follows:
[0074] Step 1: Dissolve 2g of lactic acid copolymer (Mn = 7.5w, where the molecular weight of the polyethylene glycol (PEG) block is Mn = 2w) in 4mL of chloroform, and add 0.02g of ammonium phosphomolybdate ((NH4)6P2Mo 18 O 62 Dissolve 12H2O in 0.1 mL of methanol, mix the two thoroughly, add 0.2 g of hydroxyapatite, and stir overnight at room temperature.
[0075] Step 2: Pour the mixed solution into a polytetrafluoroethylene mold and let it dry, then place it in a vacuum oven to dry the solvent.
[0076] Step 3: At 160°C, the above mixture is 3D printed into a 20mm×20mm×1mm porous scaffold (referred to as 1% PHMo) with a pore size of 500μm.
[0077] The photothermal conversion performance of the composite material under different light intensities was verified by irradiating it with a 1064nm laser.
[0078] (1) Illumination conditions: Illumination power is 0.1W cm⁻¹ -2 The light exposure distance was 1 cm, and the light exposure time was 10 min.
[0079] Under laser irradiation, the temperature of the porous stent rose rapidly, from an initial 25.5℃ to 49.7℃. The temperature increased quickly in the first 3 minutes, then plateaued and stabilized.
[0080] (2) Illumination conditions: Illumination power is 0.05W cm⁻¹ -2 The light exposure distance was 1 cm, and the light exposure time was 10 min.
[0081] Under laser irradiation, the temperature of the porous stent rose rapidly, from an initial 23.9℃ to 36.7℃. The temperature increased quickly in the first 3 minutes, then plateaued and stabilized.
[0082] (3) Lighting conditions: Light power is 0.15W cm⁻¹ -2 The light exposure distance was 1 cm, and the light exposure time was 10 min.
[0083] Under laser irradiation, the temperature of the porous stent rose rapidly, from an initial 24.2℃ to 56.5℃. The temperature increased quickly in the first 3 minutes, then plateaued and stabilized.
[0084] (4) Lighting conditions: Illumination power is 0.20W cm⁻¹ -2 The light exposure distance was 1 cm, and the light exposure time was 10 min.
[0085] Under laser irradiation, the temperature of the porous stent rose rapidly, from an initial 24.3℃ to 68.9℃. The temperature increased quickly in the first 3 minutes, then plateaued and stabilized.
[0086] Example 4
[0087] This embodiment illustrates the preparation of a porous bone repair scaffold with photothermal function. The specific steps are as follows:
[0088] Step 1: Dissolve 2g of lactic acid copolymer (Mn = 7.5w, where the molecular weight of the polyethylene glycol (PEG) block is Mn = 2w) in 4mL of chloroform, and add 0.04g of ammonium phosphomolybdate ((NH4)6P2Mo 18 O 62 Dissolve 12H2O in 0.1 mL of methanol, mix the two thoroughly, add 0.2 g of hydroxyapatite, and stir overnight at room temperature.
[0089] Step 2: Pour the mixed solution into a polytetrafluoroethylene mold and let it dry, then place it in a vacuum oven to dry the solvent.
[0090] Step 3: At 160°C, the above mixture is 3D printed into a 20mm×20mm×1mm porous scaffold (referred to as 2% PHMo) with a pore size of 500μm.
[0091] The photothermal conversion performance of the composite material was verified by irradiating it with a 1064nm laser.
[0092] Lighting conditions: Illumination power is 0.1W cm -2 The light exposure distance was 1 cm, and the light exposure time was 10 min.
[0093] Under laser irradiation, the temperature of the porous stent rose rapidly, from an initial 25.5℃ to 51.7℃. The temperature increased quickly in the first 3 minutes, then plateaued and stabilized.
[0094] Example 5
[0095] This embodiment illustrates the preparation of a porous bone repair scaffold with photothermal function. The specific steps are as follows:
[0096] Step 1: Dissolve 2g of lactic acid copolymer (Mn = 7.5w, where the molecular weight of the polyethylene glycol (PEG) block is Mn = 2w) in 4mL of dichloromethane, and add 0.02g of phosphomolybdic acid (H3PMo) 12 O 40 Dissolve H2O in 0.1 mL of ethanol, mix the two thoroughly, add 0.2 g of tricalcium phosphate, and stir overnight at room temperature.
[0097] Step 2: Pour the mixed solution into a polytetrafluoroethylene mold and let it dry, then place it in a vacuum oven to dry the solvent.
[0098] Step 3: At 170°C, the above mixture is 3D printed into a 20mm×20mm×1mm porous scaffold (referred to as 1% PTHMo) with a pore size of 500μm.
[0099] The photothermal conversion performance of the composite material was verified by irradiating it with a 1064nm laser.
[0100] Lighting conditions: Illumination power is 0.1W cm -2 The light exposure distance was 1 cm, and the light exposure time was 10 min.
[0101] Under laser irradiation, the temperature of the porous stent rose rapidly, from an initial 25.9℃ to 46.6℃. The temperature increased quickly in the first 3 minutes, then plateaued and stabilized.
[0102] Example 6
[0103] This embodiment illustrates the preparation of a porous bone repair scaffold with photothermal function. The specific steps are as follows:
[0104] Step 1: Dissolve 2g of lactic acid copolymer (Mn = 7.5w, where the molecular weight of the polyethylene glycol (PEG) block is Mn = 2w) in 4mL of dichloromethane, and add 0.02g of sodium phosphomolybdate (Na5PMo) 10 V2O 40 Dissolve in 0.1 mL of ethanol, mix the two thoroughly, add 0.2 g of tricalcium phosphate, and stir overnight at room temperature.
[0105] Step 2: Pour the mixed solution into a polytetrafluoroethylene mold and let it dry, then place it in a vacuum oven to dry the solvent.
[0106] Step 3: At 180°C, the above mixture is 3D printed into a 20mm×20mm×1mm porous scaffold (referred to as 1% PTMoV) with a pore size of 500μm.
[0107] The photothermal conversion performance of the composite material was verified by irradiating it with a 1064nm laser.
[0108] Lighting conditions: Illumination power is 0.1W cm -2 The light exposure distance was 1 cm, and the light exposure time was 10 min.
[0109] Under laser irradiation, the temperature of the porous stent rose rapidly, from an initial 25.9℃ to 49.3℃. The temperature increased quickly in the first 3 minutes, then plateaued and stabilized.
[0110] Comparative Example 1
[0111] This comparative example illustrates the preparation of a porous bone repair scaffold with photothermal function. The specific steps are as follows:
[0112] Step 1: Dissolve 2g of lactic acid copolymer (Mn = 7.5w, of which the molecular weight of polyethylene glycol (PEG) block Mn = 2w) in 4mL of chloroform, add 0.2g of hydroxyapatite, and stir overnight at room temperature.
[0113] Step 2: Pour the mixed solution into a polytetrafluoroethylene mold and let it dry, then place it in a vacuum oven to dry the solvent.
[0114] Step 3: At around 160℃, the above mixture is 3D printed into a porous scaffold (PH) of 20mm×20mm×1mm with a pore size of 500μm.
[0115] The photothermal conversion performance of the composite material was verified by irradiating it with a 1064nm laser.
[0116] Lighting conditions: Illumination power is 0.10W cm -2 The light exposure distance was 1 cm, and the light exposure time was 10 min.
[0117] Under laser irradiation, the temperature of the porous stent remained basically unchanged, rising from the initial 25.5℃ to 25.9℃, which is significantly different from the photothermal performance of the stent containing phosphomolybdenum clusters. This also indicates that the excellent photothermal performance of the stent originates from the phosphomolybdenum clusters.
[0118] Comparative Example 2
[0119] This comparative example illustrates the preparation of a porous bone repair scaffold with photothermal function. The specific steps are as follows:
[0120] Step 1: Dissolve 2g of lactic acid copolymer (Mn = 7.5w, of which the molecular weight of polyethylene glycol (PEG) block Mn = 2w) in 4mL of chloroform and stir overnight at room temperature.
[0121] Step 2: Pour the solution into a polytetrafluoroethylene mold and let it dry, then place it in a vacuum oven to dry the solvent.
[0122] Step 3: At around 160℃, the above mixture is 3D printed into a porous scaffold (P) measuring 20mm × 20mm × 1mm.
[0123] The porous scaffold was irradiated with a 1064nm laser to verify its photothermal conversion performance.
[0124] Lighting conditions: Illumination power is 0.10W cm -2 The light exposure distance was 1 cm, and the light exposure time was 10 min.
[0125] Under laser irradiation, the temperature of the porous scaffold remained essentially unchanged, increasing from an initial 25.5℃ to 25.8℃.
[0126] Comparative Example 3
[0127] This comparative example illustrates the preparation of a porous bone repair scaffold with photothermal function. The specific steps are as follows:
[0128] Step 1: Dissolve 2g of lactic acid copolymer (Mn = 7.5w, where the molecular weight of the polyethylene glycol (PEG) block is Mn = 2w) in 4mL of chloroform, and add 0.02g of ammonium phosphomolybdate (NH4)6P2Mo18 O 62 Dissolve 12H2O in 0.1 mL of methanol, mix the two thoroughly, add 0.2 g of hydroxyapatite, and stir overnight at room temperature.
[0129] Step 2: Pour the solution into a polytetrafluoroethylene mold and let it dry. Then place it in a vacuum oven to dry the solvent, and obtain the scaffold material (abbreviated as 1% PHMo-Mixture).
[0130] The photothermal conversion performance of the scaffold was verified by irradiating it with a 1064nm laser.
[0131] Lighting conditions: Illumination power is 0.10W cm -2 The light exposure distance was 1 cm, and the light exposure time was 10 min.
[0132] Under laser irradiation, the temperature of the scaffold material remained essentially unchanged, increasing from an initial 25.5℃ to 26.1℃.
[0133] Comparative Example 4
[0134] This comparative example illustrates the preparation of a porous bone repair scaffold with photothermal function. The specific steps are as follows:
[0135] Step 1: Dissolve 2g of lactic acid copolymer (Mn = 7.5w, of which the molecular weight of polyethylene glycol (PEG) block Mn = 2w) in 4mL of chloroform, add 0.2g of tricalcium phosphate, and stir overnight at room temperature.
[0136] Step 2: Pour the mixed solution into a polytetrafluoroethylene mold and let it dry, then place it in a vacuum oven to dry the solvent.
[0137] Step 3: At around 160℃, the above mixture is 3D printed into a 20mm×20mm×1mm porous scaffold (PT) with a pore size of 500μm.
[0138] The photothermal conversion performance of the composite material was verified by irradiating it with a 1064nm laser.
[0139] Lighting conditions: Illumination power is 0.10W cm -2 The light exposure distance was 1 cm, and the light exposure time was 10 min.
[0140] Under laser irradiation, the temperature of the porous stent remained basically unchanged, increasing from the initial 25.9℃ to 26.2℃, which is significantly different from the photothermal performance of the stent containing phosphomolybdenum clusters. This also indicates that the excellent photothermal performance of the stent originates from the reduced state of the phosphomolybdenum clusters.
[0141] Figure 1This illustrates step one of embodiment 3, in which lactic acid copolymer, hydroxyapatite, and ammonium phosphomolybdate (NH4)6P2Mo are mixed. 18 O 62 Image of a mixture formed when 12H2O dissolves in a solvent.
[0142] Depend on Figure 1 It can be seen that the mixed solution is a yellow solution.
[0143] Figure 2a ~f shows images of the stents prepared in Examples 1-4 and Comparative Examples 1-2.
[0144] Depend on Figure 2a As can be seen from ~f, Comparative Example 2 is the scaffold material prepared using only lactic acid copolymer, which is colorless and transparent after 3D printing. Figure 2a Comparative Example 1 is a scaffold material prepared by doping lactic acid copolymer with hydroxyapatite, which appears white after 3D printing. Figure 2b Examples 1-4 are scaffold materials made by doping lactic acid copolymer with hydroxyapatite and molybdenum phosphocosite. After 3D printing, they appear blue, and the color of the scaffold deepens further with the increase of molybdenum phosphocosite content. Figure 2c ~f).
[0145] Furthermore, by Figure 1 and Figure 2a As can be seen from the comparison, the phosphomolybdenum clusters in the system changed after 3D printing, causing their color to change from yellow to blue. In Examples 1-4, ammonium phosphomolybdenum was used as the phosphomolybdenum cluster. After fused 3D printing, the phosphomolybdenum clusters were reduced, forming reduced phosphomolybdenum clusters. Specifically, the Mo element in the added phosphomolybdenum clusters was in its highest oxidation state (Mo). 6+ After 3D printing and thermal reduction, some of the Mo elements in the corresponding phosphomolybdenum cluster structure are reduced to Mo. 5+ As a result, the mixture changes from yellow to blue after being used to create the scaffold. The reduced phosphomolybdenum clusters can act as a thermal effect component, giving the scaffold photothermal properties.
[0146] Figure 3 The infrared spectra of phosphomolybdenum ammonium (labeled PMo), hydroxyapatite (labeled HA), lactic acid copolymer (labeled P), the mixture of lactic acid copolymer, hydroxyapatite and phosphomolybdenum ammonium prepared in step one of Example 3 (labeled 1% PHMo-Mixture), and the scaffold material prepared in Example 3 (labeled 1% PHMo-3Dscaffold) are shown.
[0147] Figure 4 Infrared spectra of the scaffold materials prepared in Examples 1-4 are shown.
[0148] Depend on Figure 3 It can be seen that by performing infrared spectral analysis on the material structure under different states, the spectrum of the mixture of lactic acid copolymer, hydroxyapatite and phosphomolybdenum ammonium prepared in step one of Example 3 is consistent with the infrared spectrum of the scaffold prepared in Example 3 after 3D printing. This indicates that the structure of each component did not change before and after 3D printing. The Mo element in the phosphomolybdenum cluster only changed its valence state, and its structure did not change.
[0149] Furthermore, by Figure 4 It can be seen that the structure of each component of the scaffold prepared in Examples 1 to 4 did not change before and after 3D printing.
[0150] Figure 5 The high-resolution XPS peak fitting spectrum of the Mo 3d orbital in the mixture of lactic acid copolymer, hydroxyapatite and ammonium phosphomolybdate (2% PHMo-Mixture) prepared in step one of Example 4 is shown.
[0151] Figure 6 The high-resolution XPS peak fitting spectrum of the Mo 3d orbitals in the scaffold prepared in Example 4 is shown.
[0152] Depend on Figure 5 and Figure 6 It can be seen that the molybdenum atoms in the phosphomolybdenum cluster exhibit the highest oxidation state, Mo, in the mixture. 6+ Through the high-temperature reduction process of melt 3D printing, some molybdenum atoms are reduced to Mo. 5+ This further explains why the color of the mixed solution changed from yellow to blue after 3D printing.
[0153] Figure 7 The absorption spectra of the scaffolds prepared in Examples 1-4 and Comparative Example 3 are shown.
[0154] The scaffolds prepared in Examples 1-4 and Comparative Example 3 were dissolved in chloroform, and absorption spectra were collected. Figure 7 It can be seen that the scaffolds prepared in Examples 1-4 and Comparative Example 3 all have absorption in the near-infrared II region. However, the scaffold prepared in Comparative Example 3 (1% PHMo-Mixture) has a weaker absorption intensity in the near-infrared region. Its weak absorption in the near-infrared II region (1000-1400nm) is due to the fact that the hydroxyapatite in the composite material is insoluble in chloroform, resulting in a slightly turbid solution. Under the same conditions, the scaffolds prepared in Examples 1-4, after 3D printing, show a significant enhancement in the absorption band in the near-infrared region, especially in the near-infrared II region (1000-1400nm). This indicates that after 3D printing, the phosphomolybdenum clusters are reduced to the reduced state of phosphomolybdenum clusters, which endows the scaffolds with good near-infrared absorption performance.
[0155] Figure 8The temperature rise curves (1064 nm, 0.1 W cm⁻¹) of the stents prepared in Examples 1-4, Comparative Examples 1 and 3 are shown. -2 ).
[0156] Figure 9 The thermal images (1064 nm, 0.1 W / cm²) of the stents prepared in Examples 1-4, Comparative Examples 1 and 3 are shown. -2 ).
[0157] Depend on Figure 8 and Figure 9 It can be seen that when the above-mentioned stent is exposed to this intensity (1064 nm, 0.1 W cm⁻¹), -2 Under laser irradiation, within 10 minutes, the scaffold (PH) in Comparative Example 1, which did not contain molybdenum phosphophosphorus clusters, and the scaffold (1% PHMo-Mixture) in Comparative Example 3, which contained molybdenum phosphophosphorus clusters in the oxidized state, showed almost no temperature increase. However, the scaffolds in Examples 1-4, containing reduced molybdenum phosphophosphorus clusters, rapidly heated up in the first 3 minutes under laser irradiation, then stabilized, and even after 5 minutes of continued irradiation, the temperature remained essentially unchanged. This indicates that the photothermal effect of the scaffolds is mainly attributed to the presence of reduced molybdenum phosphophosphorus clusters, and that reduced molybdenum phosphophosphorus clusters possess excellent photothermal properties.
[0158] Furthermore, by Figure 9 It is known that as the content of reduced phosphomolybdenum clusters increases, the equilibrium temperature of the stent gradually increases. Therefore, the stent material with the required temperature can be obtained by controlling the content of reduced phosphomolybdenum clusters in the stent.
[0159] Figure 10 The temperature rise curves (1064 nm) of the scaffold prepared in Example 3 under different light irradiation powers are shown.
[0160] Figure 11 The thermal images (1064 nm) of the scaffold prepared in Example 3 under different light irradiation powers are shown.
[0161] Depend on Figure 10 and 11 It can be seen that for the same support, as the laser power increases, the equilibrium temperature of the support gradually increases. This shows that the support not only has excellent photothermal performance, but also the temperature of the support can be controlled by adjusting the laser power.
[0162] Figure 12 The temperature change curves of the scaffold prepared in Example 3 during five consecutive reversible laser irradiation / shutdown cycles are shown (1064 nm, 0.1 W cm⁻¹). -2 ).Depend on Figure 12 It can be seen that the equilibrium temperature of the stent remained basically unchanged during five consecutive laser irradiation cycles, which proves the excellent photothermal conversion stability of the stent and its good application value.
[0163] Figure 14 The temperature rise curves (1064 nm, 0.1 W cm⁻¹) of the scaffolds prepared in Examples 3, 5-6, and Comparative Example 4 are shown. -2 );
[0164] Depend on Figure 14 It can be seen that when the above-mentioned stent is exposed to this intensity (1064 nm, 0.1 W cm⁻¹), -2 Under laser irradiation, the stent (PT) in Comparative Example 4, which did not contain molybdenum phosphide clusters, showed almost no temperature increase within 10 minutes. In contrast, the stents in Examples 3, 5, and 6, containing different types of molybdenum phosphide clusters, rapidly heated up in the first 3 minutes under laser irradiation, then stabilized, and even after 5 minutes of continued irradiation, the temperature remained essentially unchanged. This indicates that the photothermal effect of the stents is mainly attributed to the presence of reduced molybdenum phosphide clusters, which possess excellent photothermal properties.
[0165] The preferred embodiments of the present invention have been described in detail above; however, the present invention is not limited thereto. Within the scope of the inventive concept, various simple modifications can be made to the technical solutions of the present invention, including combining the various technical features in any other suitable manner. These simple modifications and combinations should also be considered as the content disclosed in the present invention and are all within the protection scope of the present invention.
Claims
1. A porous bone repair scaffold with photothermal function, comprising a supporting material, an active component, and a thermal effect component, wherein the thermal effect component is a reduced phosphomolybdenum cluster.
2. The porous bone repair scaffold with photothermal function according to claim 1, characterized in that, The phosphomolybdenum cluster is selected from one or a combination of phosphomolybdic acid or phosphomolybdenum salt; preferably, the phosphomolybdenum salt is selected from one or a combination of ammonium salt or sodium salt.
3. The porous bone repair scaffold with photothermal function according to claim 2, characterized in that, The chemical formula of the phosphomolybdic acid is H3PMo. 12 O 40 H2O; The chemical formula of the phosphomolybdenum ammonium salt is (NH4)6P2Mo. 18 O 62 ·12H2O; The chemical formula of the sodium phosphomolybdate salt is Na5PMo. 10 V2O 40 .
4. The porous bone repair scaffold with photothermal function according to claim 1, characterized in that, The support material is selected from biodegradable copolymers; Preferably, the biodegradable copolymer is selected from lactic acid copolymers; Preferably, the molecular weight Mn of the lactic acid copolymer is 5-10w, more preferably 7-10w; Preferably, the lactic acid copolymer is selected from the copolymer of lactide and polyethylene glycol; Preferably, the lactic acid copolymer contains hydrophilic polyethylene glycol segments, and the molecular weight of the polyethylene glycol segments in the lactic acid copolymer is 8000 to 20000. And / or, The active ingredient is selected from one or a combination of hydroxyapatite and tricalcium phosphate.
5. The porous bone repair scaffold with photothermal function according to claim 1, characterized in that, In the scaffold, the mass ratio of the supporting material to the active component is 2.5 to 20:1, preferably 5 to 10:1; And / or, In the support structure, the mass of the thermal effect component is 0.1 to 3 wt% of the mass of the support material, preferably 0.25 to 2 wt%, and more preferably 0.5 to 1 wt%.
6. The porous bone repair scaffold with photothermal function according to claim 1, characterized in that, The pore size of the support is 200–1000 μm, preferably 300–800 μm.
7. A method for preparing a porous bone repair scaffold with photothermal function according to any one of claims 1 to 6, comprising the following steps: Step 1: Dissolve the support material in solvent A and the phosphomolybdenum cluster in solvent B respectively, then mix them evenly, add the active component and stir for a certain period of time to form a mixed solution; Step 2: Dry the mixed solution and process it into a porous bone repair scaffold under high temperature conditions.
8. The method for preparing a porous bone repair scaffold with photothermal function according to claim 7, characterized in that, In step one, Solvent A is one or a combination of dichloromethane and trichloromethane; And / or, Solvent B is one or a combination of methanol and ethanol; And / or, The mass ratio of the supporting material to the active component is 2.5 to 20:1, preferably 5 to 10:1; And / or, The mass of the phosphomolybdenum cluster is 0.1 to 3 wt% of the mass of the supporting material, preferably 0.25 to 2 wt%, and more preferably 0.5 to 1 wt%. And / or, The mixing time after mixing is 6 to 24 hours.
9. The method for preparing a porous bone repair scaffold with photothermal function according to claim 7, characterized in that, In step two, the processing method is fused 3D printing; Preferably, the processing temperature is 160°C to 180°C, more preferably 165°C to 170°C.
10. The application of the porous bone repair scaffold with photothermal function according to any one of claims 1 to 6, for repairing bone tissue; Preferably, the temperature of the scaffold is adjusted using a laser during bone tissue repair; Preferably, the wavelength of the laser is 750–1500 nm; more preferably, it is 1000–1500 nm.
Citation Information
Patent Citations
Degradable hierarchical pore composite scaffold with near-infrared light response and preparation method thereof
CN118662708A
Near-infrared light response type stent for treating femoral head necrosis as well as preparation method and application thereof
CN118787781A
